Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 22, 2023

Primary Completion Date

October 1, 2025

Study Completion Date

April 1, 2027

Conditions

Renal Cell CarcinomaMetastatic Renal Cell CarcinomaOligoprogressiveProgression

Interventions

RADIATION

Stereotactic Body Radiation Therapy

1-5 fraction Stereotactic Body Radiation Therapy to all sites of progression

Trial Locations (1)

RECRUITING

Yale University, New Haven

All Listed Sponsors

lead

Yale University

OTHER